E
Evernow
Reinventing the healthcare experience to improve women's lives before, during, and after menopause
About Evernow
Evernow is a healthcare startup that focuses on providing personalized treatment plans for women experiencing menopause and hair loss. The company operates in the telehealth market, which means it offers medical services through online platforms rather than traditional in-person visits. Evernow primarily serves women who are looking for convenient and effective solutions to manage menopause symptoms and hair loss.
The business model of Evernow is centered around a subscription-based service. Clients start by matching with a healthcare provider who recommends a customized treatment plan. Once the plan is approved, clients can receive their medications either by picking them up at a local pharmacy or having them delivered to their homes. The company offers a range of treatments, including non-hormonal prescription medications for hot flashes, estrogen pills and patches for menopause symptoms, and topical and oral solutions for hair loss.
Evernow makes money through subscription fees paid by clients for ongoing access to their personalized treatment plans and medications. The company also provides unlimited ongoing support, which includes tools to help clients track their progress and manage their care effectively.
In summary, Evernow is a telehealth startup that provides personalized treatment plans for women dealing with menopause and hair loss. It operates on a subscription-based model, offering convenience and continuous support to its clients.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- San Francisco, United States
- Employees
- 25
- Open positions
- None listed
- Dealroom signal
- 57.4/100
- Industry
- Health, Wellness Beauty
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Femtech, Sustainable Development Goals, Menopause, Hard Tech
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Apr 2022 | $29M | $114M | 8VC · Refactor Capital · Gwyneth Paltrow · Coelius Capital | ↗ |
| CONVERTIBLEEquity / VC | Sep 2021 | — | — | Alumni Ventures | — |
Growth signals
Latest recorded traffic for Evernow is 46K monthly website visits, down 29.2% over the last three months. Evernow's team declined 32.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A13 investors entered at this stage
Alumni Ventures
NEA
8VC
Refactor Capital
Gwyneth Paltrow
Coelius Capital- AWAbby Wambach
- GSGwynne Shotwell
- CHCarla Harris
Sheila Lirio Marcelo- GDGlennon Doyle
- DBDrew Barrymore
- CDCameron Diaz
Other known investors2 additional known investors
Bossa InvestHustle Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Evernow on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Evernow’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







